Abstract:Objective To study the cognitive function and the related factors in first episode depression before and after treatment.Methods Eighty patients with first-episode depression were given extended releasing venlafaxine (75-300 mg/d) or fluoxetine hydrochloride (20-40 mg/d) treatment for 12 weeks, and 41 healthy people were involved as controls. The depression severity was assessed with the 17-item Hamilton Depression Scale (HAMD), and cognitive function with a series of neuropsychological tests including the Wechsler memory scale, Wechsler adult intelligence scale and Wisconsin cards sorting test.Results The depressed patients made improvements in the neuropsychological tests after treatment (P<0.05 or P<0.01). The improvement in memory quotient (MQ) was negatively correlated to the alleviation in sleeping disturbance symptom (r=-0.26, P=0.021), improvement in short-term memory (STM) negatively to the reductions in HAMD total score and sleeping disturbance item score (r=-0.27, P=0.017; r=-0.34, P=0.002), and improvement in verbal intelligence quotient negatively to the reduction in retardation (r=-0.24, P=0.034). In comparison with controls, the recovered patients (with HAMD total score of ≤7) still had lower score on long-term memory (LTM) scale (P<0.05), and patients with residual symptoms had lower MQ score, LTM score and STM score (P<0.05). There were 18% of patients had MQ score lower than the lowerbound of normal range after the treatment, which was statistically higher than 2% of the controls (P<0.05). Conclusions The cognitive function improves after treatment in patients with first-episode depression, which is correlated to the symptoms alleviation, while nearly one-fifth of patients have memory impairment even after depression symptom remission.

The cognitive function in first-episode depression before and after therapy